Theriva Biologics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-1.5M | $17.1M |
| FY2018 | — | $17.1M | $28.9M |
| FY2019 | — | $4.9M | $26.0M |
| FY2020 | — | $-4.8M | $6.2M |
| FY2021 | — | $65.4M | $67.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-1.5M | $17.1M |
| FY2018 | — | $17.1M | $28.9M |
| FY2019 | — | $4.9M | $26.0M |
| FY2020 | — | $-4.8M | $6.2M |
| FY2021 | — | $65.4M | $67.3M |